Fisher Funds Management LTD purchased a new position in Elevance Health, Inc. (NYSE:ELV – Free Report) in the 4th quarter, Holdings Channel.com reports. The firm purchased 23,879 shares of the company’s stock, valued at approximately $8,820,000.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Raelipskie Partnership acquired a new position in shares of Elevance Health in the 3rd quarter worth approximately $26,000. Eastern Bank bought a new stake in Elevance Health in the third quarter valued at $31,000. Dunhill Financial LLC raised its stake in Elevance Health by 57.8% during the third quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock worth $37,000 after acquiring an additional 26 shares in the last quarter. Peterson Financial Group Inc. bought a new position in shares of Elevance Health during the third quarter valued at $44,000. Finally, Crews Bank & Trust acquired a new stake in shares of Elevance Health in the 4th quarter valued at $34,000. Institutional investors own 89.24% of the company’s stock.
Elevance Health Stock Performance
Shares of Elevance Health stock opened at $385.04 on Friday. The stock’s fifty day simple moving average is $385.25 and its 200 day simple moving average is $443.77. The company has a current ratio of 1.45, a quick ratio of 1.50 and a debt-to-equity ratio of 0.71. The company has a market capitalization of $89.30 billion, a PE ratio of 15.03, a PEG ratio of 1.18 and a beta of 0.83. Elevance Health, Inc. has a 12 month low of $362.21 and a 12 month high of $567.26.
Elevance Health Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 25th. Stockholders of record on Monday, March 10th will be issued a $1.71 dividend. This represents a $6.84 annualized dividend and a dividend yield of 1.78%. The ex-dividend date of this dividend is Monday, March 10th. This is a boost from Elevance Health’s previous quarterly dividend of $1.63. Elevance Health’s dividend payout ratio is 25.46%.
Wall Street Analysts Forecast Growth
Several brokerages recently issued reports on ELV. Stephens downgraded shares of Elevance Health from an “overweight” rating to an “equal weight” rating and cut their price target for the company from $520.00 to $440.00 in a report on Wednesday, January 22nd. Barclays lifted their target price on shares of Elevance Health from $501.00 to $512.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Wells Fargo & Company cut their price objective on Elevance Health from $483.00 to $478.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Truist Financial reduced their price objective on Elevance Health from $520.00 to $480.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $485.00 target price on shares of Elevance Health in a research note on Friday, January 24th. Four analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $517.03.
Read Our Latest Stock Analysis on Elevance Health
Elevance Health Company Profile
Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
See Also
- Five stocks we like better than Elevance Health
- What is the S&P/TSX Index?
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- DuPont’s Electronics Spinoff: The Start of Something Big
- Why Invest in 5G? How to Invest in 5G Stocks
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV – Free Report).
Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.